Latest research
Latest corporate research
Latest tax enhanced reviews
Subscribe to our latest research
What we do
Investment research services
Tax enhanced research services
Bespoke consulting services
About
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact us
Our team
News & events
About Hardman & Co
Case studies
The team
News, podcasts & insights
Contact Us
Twitter icon
Created with Sketch.
×
Latest corporate investment research
Detailed company analysis created specifically for investors
Latest tax enhanced research
Product reports for investors and advisors
Latest published research
Services for corporates
Investment research & analysis
Detailed company analysis created specifically for investors
Services for private Companies
Tax enhanced research
Product reports for investors and advisors.
Bespoke consulting services
Bespoke services
Services for clients with specific needs
About
About Hardman & Co.
We are the longest-established commissioned research provider.
Insights
Group
Created with Sketch.
Podcasts
Group
Created with Sketch.
Videos
Group
Created with Sketch.
Events
Group
Created with Sketch.
See all news
Group
Created with Sketch.
Podcast
The EIS Navigator
Latest Episode
24: Making big ideas investible and measuring impact | Dan Somers of Boundary Capital
Stay up-to-date with the latest research
Sign up to our newsletter
COVID-19: -
Our Commitment to Client Service & Investor Communications
Life Sciences research
Oxford BioMedica
Life Sciences
Partnering strategy delivering profitability
By
Dr Dorothea Hill
20 Sep 2018
Tissue Regenix
Life Sciences
Strategy delivering growth above expectations
By
Dr Martin Hall
14 Sep 2018
Stay up-to-date with the latest research
Sign up to our newsletter
Redx Pharma
Life Sciences
Back to the clinic
By
Dr Dorothea Hill
06 Sep 2018
Avacta Group plc
Life Sciences
Capital increase for further development
By
Dr Martin Hall
05 Sep 2018
Bionomics Ltd
Life Sciences
FY’18 – focus on PTSD drug development
By
Dr Martin Hall
03 Sep 2018
Advanced Oncotherapy
Life Sciences
Treatment planning system agreement
By
Dr Martin Hall
29 Aug 2018
Oxford BioMedica
Life Sciences
Risk-sharing in cystic fibrosis gene-therapy
By
Dr Dorothea Hill
14 Aug 2018
Tissue Regenix
Life Sciences
1H’18 preview: organic plus inorganic growth
By
Dr Martin Hall
02 Aug 2018
Alliance Pharma Plc
Life Sciences
2018: a year of international progress
By
Dr Martin Hall
01 Aug 2018
Avacta Group plc
Life Sciences
Ground-breaking new drug conjugate platform
By
Dr Martin Hall
30 Jul 2018
Scancell Holdings
Life Sciences
SCIB1 – Strong survival data
By
Dr Martin Hall
18 Jul 2018
Prev
1
...
7
8
9
10
11
...
17
Next
